Inotek Pharmaceuticals (United States)

586 papers and 24.1k indexed citations i.

About

In recent decades, authors affiliated with Inotek Pharmaceuticals (United States) have published 586 papers, which have received a total of 24.1k indexed citations. Scholars at this organization have produced 156 papers in Electrical and Electronic Engineering, 141 papers in Atomic and Molecular Physics, and Optics and 97 papers in Oncology on the topics of PARP inhibition in cancer therapy (91 papers), Adaptive optics and wavefront sensing (58 papers) and Optical measurement and interference techniques (48 papers). Their work is cited by papers focused on Molecular Biology (5.6k citations), Oncology (4.7k citations) and Atomic and Molecular Physics, and Optics (3.8k citations). Authors at Inotek Pharmaceuticals (United States) collaborate with scholars in United States, Hungary and Germany and have published in prestigious journals including Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry. Some of Inotek Pharmaceuticals (United States)'s most productive authors include Csaba Szabó, Jon G. Mabley, Richard Barakat, Lucas Liaudet, László Virág, Pál Pacher, I. C. Chang, James C. Wyant, Andrew L. Salzman and György Haskó.

In The Last Decade

Fields of papers published by authors at Inotek Pharmaceuticals (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Inotek Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Inotek Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Inotek Pharmaceuticals (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Inotek Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Inotek Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inotek Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025